To discuss the integration of digital and molecular pathology in breast and gynecologic cancers, emphasizing its significance for practical clinical applications and emerging research.
Key Findings:
Digital pathology has evolved from archiving to a quantitative platform that integrates with AI for improved diagnostics, significantly impacting clinical decision-making.
AI and ML enable the detection of complex morphologic patterns and predict clinical outcomes, enhancing the accuracy of diagnoses.
Foundation models in AI show superior performance in diagnostic tasks with limited data, indicating a shift towards more robust AI applications in pathology.
Interpretation:
The integration of digital pathology and AI represents a significant advancement in the diagnosis and treatment of breast and gynecologic cancers, facilitating a more holistic approach to patient care and improving clinical outcomes.
Limitations:
Challenges in standardization and reproducibility may hinder widespread clinical adoption, necessitating collaborative efforts to establish best practices.
Regulatory issues and workflow integration remain significant barriers, highlighting the need for ongoing dialogue with regulatory bodies.
Conclusion:
The review underscores the potential of multimodal data integration in enhancing cancer diagnostics and treatment, while also highlighting the need for addressing existing challenges to fully realize these advancements.
